A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study

被引:7
|
作者
Liu, Sen [1 ]
Zhang, Bing [1 ,2 ]
Rowan, Brian G. [1 ]
Jazwinski, S. Michal [3 ,4 ]
Abdel-Mageed, Asim B. [5 ]
Steele, Chad [6 ]
Wang, Alun R. [7 ]
Sartor, Oliver [5 ,8 ]
Niu, Tianhua [9 ]
Zhang, Qiuyang [1 ,4 ,8 ]
机构
[1] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA
[2] ShenZhen LuoHu Peoples Hosp, Med Lab, Shenzhen, Peoples R China
[3] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
[4] Tulane Univ, Sch Med, Tulane Ctr Aging, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA
[6] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA
[7] Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[8] Tulane Univ, Sch Med, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA
[9] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA
基金
美国国家卫生研究院;
关键词
cre-expressing adenovirus; age; prostate cancer; Pten; mouse models; TUMOR-SUPPRESSOR GENE; TRANSGENIC MOUSE; CRE RECOMBINASE; MICE; INACTIVATION; PTEN/MMAC1; EXPRESSION; DELETION; PATHWAY; LEADS;
D O I
10.3389/fmolb.2021.696537
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostate cancer (PCa) is associated with advanced age, but how age contributes to prostate carcinogenesis remains unknown. The prostate-specific Pten conditional knockout mouse model closely imitates human PCa initiation and progression. To better understand how age impacts PCa in an experimental model, we have generated a spatially and temporally controlled Pten-null PCa murine model at different ages (aged vs. non-aged) of adult mice. Here, we present a protocol to inject the Cre-expressing adenovirus with luciferin tag, intraductally, into the prostate anterior lobes of Pten-floxed mice; Pten-loss will be triggered post-Cre expression at different ages. In vivo imaging of luciferin signal following viral infection confirmed successful delivery of the virus and Cre activity. Immunohistochemical staining confirmed prostate epithelial-specific expression of Cre recombinase and the loss of Pten and activation of P-Akt, P-S6, and P-4E-BP1. The Cre-expression, Pten ablation, and activated PI3K/AKT/mTOR pathways were limited to the prostate epithelium. All mice developed prostatic epithelial hyperplasia within 4 weeks after Pten ablation and prostatic intraepithelial neoplasia (PIN) within 8 weeks post-Pten ablation. Some PINs had progressed to invasive adenocarcinoma at 8-16 weeks post-Pten ablation. Aged mice exhibited significantly accelerated PI3K/AKT/mTOR signaling and increased PCa onset and progression compared to young mice. The viral infection success rate is similar to 80%. This model will be beneficial for investigations of cancer-related to aging.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Integrative analysis of transcriptomic, proteomic, and metabolomic data of Pten-knockout carcinogenic mouse prostate
    Zhang, Jinhui
    Li, Li
    Kim, Sangyub
    Higgins, LeeAnn
    Deng, Yibin
    Kemp, Christopher J.
    Jiang, Cheng
    Lu, Junxuan
    CANCER RESEARCH, 2017, 77
  • [2] Aqueous metabolome of tissue-specific conditional Pten-knockout mouse prostate cancer and TRAMP neuroendocrine carcinoma
    Kim, Sangyub
    Li, Li
    Zhang, Jinhui
    Jiang, Cheng
    Lu, Junxuan
    PROSTATE, 2022, 82 (01): : 154 - 166
  • [3] Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse
    Wang, Lei
    Guo, Xiaolan
    Wang, Ji
    Jiang, Cheng
    Bosland, Maarten C.
    Lu, Junxuan
    Deng, Yibin
    CANCER PREVENTION RESEARCH, 2016, 9 (01) : 35 - 42
  • [4] PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid
    Wang, Lujing
    Wang, Chao
    Sarwar, Md Shahid
    Chou, Pochung
    Wang, Yujue
    Su, Xiaoyang
    Kong, Ah-Ng Tony
    FASEB JOURNAL, 2022, 36 (11):
  • [5] Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer
    Zhang, Jinhui
    Kim, Sangyub
    Li, Li
    Kemp, Christopher J.
    Jiang, Cheng
    Lu, Junxuan
    PROSTATE, 2020, 80 (07): : 588 - 605
  • [6] PTEN Knockout Prostate Cancer as a Model for Experimental Immunotherapy
    Haga, Kazunori
    Tomioka, Atsushi
    Liao, Chun-Peng
    Kimura, Takahiro
    Matsumoto, Hiroshi
    Ohno, Izumi
    Hermann, Kip
    Logg, Christopher R.
    Jiao, Jing
    Tanaka, Motoyoshi
    Hirao, Yoshihiko
    Wu, Hong
    Kruse, Carol A.
    Roy-Burman, Pradip
    Kasahara, Noriyuki
    JOURNAL OF UROLOGY, 2009, 181 (01): : 354 - 362
  • [7] Oral administration of Withaferin-A effectively suppresses prostate carcinogenesis in PTEN-Knockout mice
    Damodaran, Chendil
    Suman, Suman
    Das, Trinath P.
    Alatassi, Houda
    Ankem, Murali K.
    CANCER RESEARCH, 2016, 76
  • [8] Generation of PTEN-knockout (-/-) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling
    Takao, Akiko
    Yoshikawa, Kazuhiro
    Karnan, Sivasundaram
    Ota, Akinobu
    Uemura, Hirotsugu
    De Velasco, Marco A.
    Kura, Yurie
    Suzuki, Susumu
    Ueda, Ryuzo
    Nishino, Tokiko
    Hosokawa, Yoshitaka
    ONCOLOGY REPORTS, 2018, 40 (05) : 2455 - 2466
  • [9] Accumulation of progenitor cells in the luminal epithelial cell layer in a targeted Pten knockout mouse prostate cancer model
    Korsten, H.
    Ziel-Van der Made, A.
    Ma, X.
    Van Leenders, A.
    Van der Kwast, T.
    Trapman, J.
    BJU INTERNATIONAL, 2007, 100 : 2 - 2
  • [10] Loss of ATF3 promotes akt activation and prostate cancer development in a pten knockout mouse model
    Wang, Ziyan
    Xu, Dong
    Yan, Chunhong
    CANCER RESEARCH, 2015, 75